Homo sapiensSystemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance
出版年份 2011 全文链接
标题
Homo sapiensSystemic RNA Interference-defective-1 Transmembrane Family Member 1 (SIDT1) Protein Mediates Contact-dependent Small RNA Transfer and MicroRNA-21-driven Chemoresistance
作者
关键词
-
出版物
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 8, Pages 5267-5277
出版商
American Society for Biochemistry & Molecular Biology (ASBMB)
发表日期
2011-12-16
DOI
10.1074/jbc.m111.318865
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- MicroRNA-21: A novel therapeutic target in human cancer
- (2011) Xuan Pan et al. CANCER BIOLOGY & THERAPY
- Connexin-26 Is a Key Factor Mediating Gemcitabine Bystander Effect
- (2011) L. Garcia-Rodriguez et al. MOLECULAR CANCER THERAPEUTICS
- A Phagocytic Route for Uptake of Double-Stranded RNA in RNAi
- (2011) João J. E. Rocha et al. PLoS One
- SID-1 is a dsRNA-selective dsRNA-gated channel
- (2011) J. D. Shih et al. RNA
- Follicular dendritic cell-dependent drug resistance of non-Hodgkin lymphoma involves cell adhesion-mediated Bim down-regulation through induction of microRNA-181a
- (2010) T. Lwin et al. BLOOD
- Functional MicroRNA Is Transferred between Glioma Cells
- (2010) M. Katakowski et al. CANCER RESEARCH
- MicroRNA-21 in Pancreatic Cancer: Correlation with Clinical Outcome and Pharmacologic Aspects Underlying Its Role in the Modulation of Gemcitabine Activity
- (2010) Elisa Giovannetti et al. CANCER RESEARCH
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- MicroRNA: Biogenesis, Function and Role in Cancer
- (2010) Leigh-Ann MacFarlane et al. CURRENT GENOMICS
- Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line
- (2010) Haitao Bai et al. FEBS LETTERS
- Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas
- (2010) J Lin et al. LEUKEMIA
- Gemcitabine intercellular diffusion mediated by gap junctions: new implications for cancer therapy
- (2010) Sylvine Cottin et al. Molecular Cancer
- Small RNAs are on the move
- (2010) Daniel H. Chitwood et al. NATURE
- MicroRNA control of signal transduction
- (2010) Masafumi Inui et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- AP-1-Dependent miR-21 Expression Contributes to Chemoresistance in Cancer Stem Cell-Like SP Cells
- (2010) Aya Misawa et al. ONCOLOGY RESEARCH
- Electrotonic loading of anisotropic cardiac monolayers by unexcitable cells depends on connexin type and expression level
- (2009) Luke C. McSpadden et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Tumor-stromal interactions with direct cell contacts enhance proliferation of human pancreatic carcinoma cells
- (2009) Hayato Fujita et al. CANCER SCIENCE
- A phase I and pharmacokinetic study of gemcitabine given by 24-h hepatic arterial infusion
- (2009) J.M. van Riel et al. EUROPEAN JOURNAL OF CANCER
- Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs
- (2009) O. Rechavi et al. GENES & DEVELOPMENT
- Cell-cell contact globally activates microRNA biogenesis
- (2009) H.-W. Hwang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- miR-21: a small multi-faceted RNA
- (2008) Anna M. Krichevsky et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- RNAs as extracellular signaling molecules
- (2008) Marcel E Dinger et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Prolonged Versus Standard Gemcitabine Infusion: Translation of Molecular Pharmacology to New Treatment Strategy
- (2008) S. A. Veltkamp et al. ONCOLOGIST
- Exploring systemic RNA interference in insects: a genome-wide survey for RNAi genes in Tribolium
- (2008) Yoshinori Tomoyasu et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started